Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Also employed in agrochemicals to improve metabolic stability and bioavailability. The trifluoromethyl group contributes to lipophilicity and resistance to oxidative degradation, making it valuable in designing long-acting drugs. Additionally, it serves as a building block in materials science for creating fluorinated organic semiconductors with improved electron transport properties.